Lexeo Therapeutics

Lexeo Therapeutics

NY - New York
Biotechnology1 H-1B visas (FY2023)

Focus: Gene Therapy

Lexeo Therapeutics is a life sciences company focused on Gene Therapy.

Gene Therapy
Open Jobs
5

Pipeline & Clinical Trials

A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients Wi
Arrhythmogenic Cardiomyopathy
N/A
Clinical Trials (1)
NCT06976606A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM
N/A
Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 P
Arrhythmogenic Cardiomyopathy
N/A
Clinical Trials (1)
NCT07050160Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant
N/A
Clinical Course Of Disease In Participants With FA-CM
Friedreich Ataxia
N/A
Clinical Trials (1)
NCT06865482Clinical Course Of Disease In Participants With FA-CM
N/A
Phase 1
Clinical Trials (1)
NCT05400330Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Disease
Phase 1
Phase 1/2
Clinical Trials (1)
NCT03634007Gene Therapy for APOE4 Homozygote of Alzheimer's Disease
Phase 1/2
Low dose LX2006
Friedreich Ataxia
Phase 1/2
Clinical Trials (1)
NCT05445323Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia
Phase 1/2
Clinical Trials (1)
NCT06109181Gene Therapy for ACM Due to a PKP2 Pathogenic Variant
Phase 1/2

Open Jobs (5)

Interview Prep Quick Facts
Portfolio: 7 clinical trials
H-1B (2023): 1 approval
Open Roles: 5 active jobs

Hiring Trend

Stable
5
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub